Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

Related Citations for PubMed (Select 6140490)

1.

Decreased ratio of CSF acetylcholinesterase to butyrylcholinesterase activity in Alzheimer's disease.

Arendt T, Bigl V, Walther F, Sonntag M.

Lancet. 1984 Jan 21;1(8369):173. No abstract available.

PMID:
6140490
2.

Cholinesterases in cerebrospinal fluid. Correlations with clinical measures in Alzheimer's disease.

Huff FJ, Maire JC, Growdon JH, Corkin S, Wurtman RJ.

J Neurol Sci. 1986 Feb;72(2-3):121-9.

PMID:
3711929
5.

Cholinesterases in the cerebrospinal fluid, plasma, and erythrocytes of patients with Alzheimer's disease.

Sirviö J, Kutvonen R, Soininen H, Hartikainen P, Riekkinen PJ.

J Neural Transm. 1989;75(2):119-27.

PMID:
2918304
6.

Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.

Sáez-Valero J, Fodero LR, Sjögren M, Andreasen N, Amici S, Gallai V, Vanderstichele H, Vanmechelen E, Parnetti L, Blennow K, Small DH.

J Neurosci Res. 2003 May 15;72(4):520-6.

PMID:
12704813
7.

Cholinesterases in cerebrospinal fluid. A longitudinal study in Alzheimer disease.

Elble R, Giacobini E, Scarsella GF.

Arch Neurol. 1987 Apr;44(4):403-7.

PMID:
3827696
8.

The significance of the activity of CSF cholinesterases in dementias.

Shen ZX.

Med Hypotheses. 1996 Nov;47(5):363-76.

PMID:
8951800
9.

Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems.

Ruberg M, Villageois A, Bonnet AM, Pillon B, Rieger F, Agid Y.

J Neurol Neurosurg Psychiatry. 1987 May;50(5):538-43.

10.

Altered glycosylation of cerebrospinal fluid butyrylcholinesterase in Alzheimer's disease.

Sáez-Valero J, Small DH.

Brain Res. 2001 Jan 19;889(1-2):247-50.

PMID:
11166713
11.

Cerebrospinal fluid levels of biomarkers and activity of acetylcholinesterase (AChE) and butyrylcholinesterase in AD patients before and after treatment with different AChE inhibitors.

Parnetti L, Amici S, Lanari A, Romani C, Antognelli C, Andreasen N, Minthon L, Davidsson P, Pottel H, Blennow K, Gallai V.

Neurol Sci. 2002 Sep;23 Suppl 2:S95-6.

PMID:
12548360
12.
13.
14.

[Cholinesterases and their importance in the etiology, diagnosis and therapy of Alzheimer's disease].

Patocka J, Strunecká A, Rípová D.

Cesk Fysiol. 2001 Feb;50(1):4-10. Review. Czech.

PMID:
11268561
15.

Cerebrospinal fluid acetylcholinesterase homospecific activity in patients with "probable Alzheimer's disease".

Konings CH, Scheltens P, Kuiper MA, Mulder C, Calliauw J, Wolters EC.

Biol Psychiatry. 1994 Nov 15;36(10):708-9. No abstract available.

PMID:
7880942
16.

Anomalous acetylcholinesterase in lumbar CSF in Alzheimer's disease.

Smith AD, Jobst KA, Navaratnam DS, Shen ZX, Priddle JD, McDonald B, King E, Esiri MM.

Lancet. 1991 Dec 14;338(8781):1538. No abstract available.

PMID:
1683967
17.

Anomalous acetylcholinesterase in CSF without clinical diagnosis of Alzheimer's disease.

Shen ZX, Zhang Z.

Lancet. 1993 Jul 3;342(8862):62. No abstract available.

PMID:
8100344
18.

Dopamine-beta-hydroxylase and acetylcholinesterase activities of cerebrospinal fluid in Alzheimer's disease.

Soininen H, Pitkänen A, Halonen T, Riekkinen PJ.

Acta Neurol Scand. 1984 Jul;70(1):29-34.

PMID:
6147948
19.

Molecular forms of cholinesterases in CSF of Alzheimer's disease/senile dementia of Alzheimer type patients and matched neurological controls.

Bisso GM, Masullo C, Michalek H, Silveri MC, Pocchiari M.

Life Sci. 1986 Feb 10;38(6):561-7.

PMID:
3945178
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk